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Magnesium plays a critical role in glucose metabolism and evidence suggest that magnesium deficiency 
is  assoc ia ted with decreased insul in s ensi t ivi ty .  However, i t  is l ik ely  that  thes e relationships 
are affected by genetic and environmental factors that can differ among different populations. The aim 
of this study was to determine the prevalence of insulin resistance and its association with magnesium 
status among apparently healthy adult Nigerians. Fasting plasma levels of magnesium, glucose and 
insulin were determined in 120 apparently healthy adults. Insulin resistance was calculated as HOMA-
IR. Prevalence of insulin resistance was est ima ted a nd the  ass ociat ion  between plas ma  
magnes ium l evels  a nd HOMA-IR was determined. About 19.2% of the study subjects were classified 
as having insulin resistance. Prevalence was higher among males compared to females (21.0% vs 17.0%) 
and among obese compared to normal-weight  s ubjects  (26.1% vs  14.9%).  Subjects with  
hypomagnes emia    had a higher  prevalence of insulin resistance compared with subjects who had 
normal plasma magnesium levels  (50.0% vs 14.4%). Insulin resistance was inversely associated with 
plasma magnesium level independent of age, gender and BMI. Insulin resis ta nc e is  relatively c ommon 
among apparently heal thy  individuals in  this study. Magnesium def iciency  was  found  to be a  
s igni f icant  predic tor  of  ins ul in  res is ta nc e.  We recommend further studies that will investigate 
whether optimization of magnesium status in general population or among individuals at risk of 
developing type 2 diabetes will be a useful approach in lowering insulin resistance and prevent or delay 
the onset of type 2 diabetes mellitus in our setting. 
 
 
Keywords: Magnesium; Insulin Resistance; Adult; Body mass index; Nigeria 
 
*Corresponding author email: drgombe@gmail.com   Tel: +2347037691408 
Sierra Leone Journal of Biomedical Research 
A publication of the College of Medicine and Allied Health Sciences, University of Sierra Leone 
© Sierra Leone Journal of Biomedical Research                                                        SSN 2076-6270 (Print) 
Vol 10(2), pp.5-11, December, 2018                                                                    ISSN 2219-3170 (Online 
First) 
 
   






Insulin resis ta nc e is   defined  as  a  state  in  
which  more  insulin  is  required  to  obtain  
the  physiological effects achieved by a lower 
insulin level in a healthy state [Lebovitz, 
2001]. It plays a vital role in the pathogenesis 
of type 2 diabetes mellitus. It is the precursor 
or driving factor that leads to type 2 diabetes 
mellitus [Lebovitz, 2001]. Insulin resistance is 
also reported to be strongly associated with 
increased risk of the development of 
hypertension, cardiovascular disease, 
dyslipidemia and metabolic syndrome 
[Lebovitz, 2001; Paul, 2009]. 
 
The exact cause of insulin resistance is not 
fully understood; however, a number of 
mechanisms have been suggested as possible 
factors underlying the pathogenesis of the 
insulin resistance. Magnesium  is the second 
most abundant intracellular cation and is 
involved in carbohydrate metabolism as a 
cofactor in several enzymatic reactions 
[Swaminathan, 2003].  
 
Previous studies done mostly among 
Caucasians and African Americans, suggested 
that magnesium may play a significant   role  in  
enhancing/improving   insulin   sensitivity   in  
healthy  subjects   and  that maintaining  optimal  
magnesium  status  may  attenuate  onset  of  
type  2  diabetes  mellitus  in individuals at risk 
[Paolisso et al., 1992; Guerrero-Romero et al., 
2004; Larsson, Wolk, 2007; Kao et al., 1999].  
However,  it is likely that these relationships  
are affected  by genetic  and environmental 
factors that can differ among different 
populations. There is limited data on the impact  
of  magnesium  deficiency  on  the present study 
was therefore designed to determine the 
prevalence of insulin resistance among  
apparently healthy individuals in our setting. 
 
The present study was therefore designed to 
determine the preval enc e of  ins ul in 
resista nc e a nd i ts  relationship  with  
magnesium  status,  as  measured  by  plasma  
magnesium  level  among apparently healthy 
Nigerian adults. 
 
Subjects and Methods 
 
This was a cross-sectional analytical study 
including one hundred and twenty (120) 
apparently healthy  adults  volunteers  (78 
males  and  52 females)  aged  greater  than  18  
years  who  gave  informed consent. They were 
enrolled in to the study from individuals who 
presented to the general outpatient clinic of the 
Gombe State Specialist Hospital, Gombe and 
Federal Teaching Hospital,  Gombe,  Nigeria,  for  
routine  medical  check-up,  pre  marital  
screening  and  blood donors. All study subjects 
are Nigerians of African descent and living in 
Gombe State. Subjects with diagnosed diabetes 
mellitus or any other illness, those who smoke 
or  ingest  alcohol, pregnant  and breastfeeding  
mothers  were  excluded  from the study.  The 
study protocol  was  approved  by the health 
research  ethics  committees  of the Gombe  
State Ministry  of Health, Gombe and Federal 
Teaching Hospital, Gombe. 
 
History and physical examination were 
performed in each of the study subjects at the 
time of blood sample collection. Information on 
age, sex and past medical history were obtained 
from each subject  and recorded. 
 
Standing height was measured  to the nearest 
centimeter using a stadiometer. Body weight 
was measured to the nearest 0.1 kilogram. 
Measurement of height and weight were done 
with the study subjects in light clothing 
without head gear or shoes. Body mass index 
was calculated as a ratio of weight in kilogram 
and height in meters squared and expressed as 
kg/m2. 
 
Laboratory Analysis  
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Fasting venous blood samples were collected 
in the morning following 10-12 hours 
overnight fas ting  into heparin bottles. Blood 
samples were immediately centrifuged for 15 
minutes for Sierra Leone Journal of Biomedical 
Research assayed us ing  a commercially  
available  human  insulin  enzyme-linked  
immunosorbent  assay (ELISA)  kit  (Monobind  
Inc.  USA).  Glucose was  measured  using  
glucose  oxidase  method  (Agappe  Diagnostics  
Limited,  India).  All laboratory  a nal ys es   
were  done  at  the  Chemical Pathology 
laboratory of Gombe State University/Federal 
Teaching Hospital, Gombe. 
 
Calculation of Indices 
 
Insulin resistance was calculated as 
Homeostatic Model Assessment-IR (HOMA-IR). 
HOMA-IR  = Fasting plasma insulin (FPI) × 
Fasting plasma glucose (FPG) / 22.5 [Wallace, 




Hypomagnesaemia was defined as plasma 
magnesium level < 0.75mmol/L [Costello,  
2016]. Insulin Resistance was defined as 




Statistical  package  for social sciences  (SPSS)  
version  20.0 was used for statistical  analysis. 
Kolmogorow-Smirnov Shapiro-Wilk tests were 
used to test for normality of distribution of 
data and logarithmic  transformation  was used 
to improve the normality of distribution  of 
skewed data. Quantitative variables were 
presented using  proportions and measures of 
central tendency and dispersion. Mean 
differences of plasma magnesium and HOMA-
IR between groups were compared using t-test. 
Partial correlation and linear regression 
analyses were used to determine relationship 
between plasma magnesium levels and HOMA-
IR and to adjust for confounders. All p-values 
were two-sided and considered significant if 




Demographic and biochemical characteristics 
of the study subjects are presented in Table 1. 
The mean age of the study subjects, which 
were predominantly males (55.8%), was 37.2 
± 3.5 years and the mean BMI was 26.1 ± 3.3 
kg/m2. There were no significant differences 
in the age and BMI levels between males and 
females subjects (39.1 ± 4.1 vs. 34.8 ± 3.2 
years, p > 0.05) and (26.5 ± 3.1 vs. 25.6 ± 2.4 
kg/m2, p > 0.05) respectively. 
 
Prevalence of insulin resistance among the 
study subjects were presented in Tables 2 and 
3. About 19.2% of the study subjects were 
found to have insulin resistance. Prevalence of 
insulin resistance was higher among male than 
female subjects (21.0% vs. 17.0%) and in 
obese subjects compared with normal weight 
subjects (26.1% vs. 14.9%). Prevalence  of 
insulin  resistance  was also determined 
according  to plasma magnesium level. Subjects 
with hypomagnesemia  had higher prevalence 
of insulin resistance than subjects with normal 
plasma magnesium levels in both genders and 
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Figure 1: Frequency of insulin resistance among the 






Table 3: Prevalence of Insulin resistance in relation to 




The relationship between plasma  magnesium  and  
degree  of  insulin  resistance  in  the  study subjects was 
examined (Table 4 and Figure 2.). A significant inverse 
relationship, independent of  age and BMI, was found 
between plasma magnesium levels and HOMA-IR (r = -
0.55, p < 0.05) in  all  the  study  subjects.  When  the  
study  subjects  were  categorized  into  males  and 
females,  the  inverse relationships  between  plasma  
magnesium  levels  and  HOMA-IR  was observed to be 










Table 4: Correlation of HOMA-IR with anthropometric and 
biochemical factors 
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HOMA-IR, homeostasis model assessment-insulin resistance 
BMI, body mass index  
r, correlation coefficient  
DM, Diabetes mellitus 
HOMA-IR, homeostasis model assessment-insulin resistance 
BP, blood pressure 




Figure 2: Correlation of plasma magnesium level and 




We studied the prevalence of insulin resistance and its 
association with magnesium status, as measured by 
plasma magnesium level in a group of apparently 
healthy adult Nigerians. In this present study, we 
reported 19.2% as the overall prevalence of  insulin 
resistance among  the study subjects. The prevalence 
was observed to be higher among male than female 
subjects and in overweight compared to normal weight 
subjects regardless of gender. We also observed that 
magnesium deficiency is significantly associated with 
increased frequency of insulin resistance among the 
study subjects irrespective of gender and body weight 
status. Reports on prevalence of insulin resistance 
among general population vary widely ranging from 
17% to 61% [Bermudez et al., 2016; Friedrich et al., 
2012;  Do et al., 2010; Huguette et al., 2010; Young et 
al., 2016]. The wide range/disparity might be 
explained by heterogeneity of the study population, 
definition of insulin resistance and methods of assay of 
insulin used in the various studies. Studies conducted 
among lean and young individuals generally reported 
lower prevalence. 
 
Our result of higher prevalence  of insulin resistance 
among males compared to females was similar to 
reports from studies conducted by Friedrich et al 
[Friedrich et al., 2012] and Do et al [Do et al.,  2010].  
Obese  subjects  were  also  observed  to have higher  
prevalence  of  insulin resistance than normal weight 
subjects  regardless of gender. The same finding was 
reported by Bermudez et al [Bermudez et al., 2016]. 
 
In the present study we reported a significantly higher 
frequency of insulin resistance among subjects with 
hypomagnesemia compared to subjects with normal 
plasma magnesium levels and that decreased plasma 
levels of magnesium  is significantly  associated  with 
increased  insulin resistance among the study subjects 
independent of age, gender and body mass index.  
 
Similar  findings  have been reported  in many previous  
studies,  where  hypomagnesemia  was shown to be 
associated with increased insulin resistance [Guerrero-
Romero, Rodríguez-Morán, 2013; Humphries et al., 
1999; Huerta et al., 2005;  Rosolova et al., 2000; 
Resnick et al., 1990]. 
Also in support of the results of this study Nadler et al. 
showed that induced hypomagnesemia 
is associated with decreased insulin secretion and 
action [Nadler et al., 1993]. In addition it was found 
that low dietary magnesium intake among apparently 
healthy adults are associated with higher  risk of 
developing  type 2 diabetes  mellitus  [Kao et al.,  1999;  
Lopez-Ridaura et al., 2004]. Although Cahill F et al, 
reported that high dietary magnesium intake is 
associated with low insulin 
 
resistance, they did not find significant relationship 
between serum magnesium and insulin resistance 
[Cahill et al., 2013]. The inconsistencies  in the reports 
from the various studies might be due to the variation  
in sample  size  and  experimental   conditions.   
Heterogeneity   of  the  study subjects, such  as 
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differences  in age,  gender proportion,  BMI  and  health  
status,  and  differences  in the assay methods used in 
analysis of plasma magnesium and insulin levels might 
also contribute to the discrepancies. Several 
mechanisms by which magnesium deficiency could 
contribute to the development of insulin  resistance  
have  been  proposed.  Magnesium is  required  for  
autophosphorylation  of insulin receptor. Binding of 
two magnesium ions to the tyrosine kinase domain of 
the insulin receptor enhances the tyrosine kinase 
activity by increasing the affinity of the receptor to ATP 
[Gommers  et al., 2016]. In magnesium  deficiency state 
therefore,  there is decreased  insulin receptor 
phosphorylation, and therefore decreased insulin 
sensitivity [Gommers et al., 2016].    Increased 
expression of inflammatory markers and reactive 
oxygen species in individuals with magnesium  
deficiency  has  also  been  proposed  to  contribute  to  
the  insulin  resistance  in magnesium deficiency states 
[Guerrero-Romero, Rodríguez-Morán, 2006]. 
 
LIMITATIONS 
HOMA-IR  is  only  surrogate  marker  of  insulin  
resistance  based  on  fasting  insulin  and glucose levels 
and plasma magnesium, rather than  intracellular 
magnesium, a more sensitive indicator of magnesium 
status, was measured. The extent to which these might 
have affected the outcome of this study needs to be 
further investigated. Because of the cross-sectional 
nature of this study, we cannot be certain of a 
causal/temporal relationship between magnesium and 
insulin resistance. The  study  subjects  were  mainly  
from Fulani  ethnic  group,  so the findings  may  not  be 




We conclude that among apparently healthy adult 
individuals in this study, insulin resistance is relatively 
common and lower plasma magnesium is associated 
with increased insulin resistance as measured by 
HOMA-IR. This finding may require replication from 
studies involving larger sample  size and various  ethnic  
groups.  We recommend  further  studies  that will 
investigate whether increasing dietary consumption of 
foods rich in magnesium, such as whole grains and 
green vegetables and/or magnesium   supplementation 
in   general   population   or among individuals at risk 
of developing type 2 diabetes will be a useful approach 
in lowering insulin resistance  and  preventing  (and/or  
delay)  type  2  diabetes  mellitus  in  our  setting.  We  
also recommend large scale study that will establish an 
evidence-based local reference interval that will allow 
more accurate assessment of the prevalence  of 
insulinresistance among our local population. 
 
Acknowledgement 
We would like to thank staff of the Department of 
Health Records, Federal Teaching Hospital,Gombe for 
their help in acquiring the data. We are also grateful to 
all the study participants. 
There was no external funding source. The study was 
funded by personal financial contributionsfrom the 
authors. 
 
REF ERENCES  
 
Bermudez  V, Salazar  J, Martínez  MS,  Chávez-Castillo  
M,  Olivar  LC, Calvo  MJ, et al. 2016) Prevalence and 
Associated Factors of Insulin Resistance in Adults from 
Maracaibo City, Venezuela.  Adv Prev Med. 2016: 
9405105. 
Cahill F, Shahidi M, Shea J, Wadden D, Gulliver W, 
Randell E, et al. (2013) High Dietary Magnesium  Intake  
Is  Associated  with  Low  Insulin  Resistance  in  the  
Newfoundland Population. PLoS ONE. 8(3): e58278. 
Costello RB, Elin RJ, Rosanoff A, Guerrero-Romero F, 
Hruby A, Lutsey PL, et al. (2016) 
 
Perspective: the case for an evidence-based  reference 
interval for serum magnesium: The time has come. 
Do HD,Lohsoonthorn   V,  Jiamjarasrangsi   W,  
Lertmaharit   S,  Williams  MA.  (2010) 
Prevalence of insulin resistance and its relationship 
with cardiovascular disease risk factors among Thai 
adults over 35 years old. Diabetes Res Clin Pract. 89(3): 
303-308. 
 
Friedrich N, Thuesen B, Jørgensen T, Juul A, Spielhagen 
C, Wallaschofksi H, et al. (2012) 
The association between IGF-I and insulin resistance: a 
general population study in Danish adults. Diabetes 
Care. 35(4):768-773. 
Sierra Leone Journal of Biomedical Research 
A publication of the College of Medicine and Allied Health Sciences, University of Sierra Leone 
© Sierra Leone Journal of Biomedical Research                                                        SSN 2076-6270 (Print) 
Vol 10(2), pp.5-11, December, 2018                                                                    ISSN 2219-3170 (Online First) 
 
   
Sierra Leone J Biomed Res Dec, 2018 Vol. 10 No 2                   http://www.sljbr.org/index.php              11 
http://dx.doi.org/10.4314/sljbr.v10i2.2  
 
Gommers LMM,  Hoenderop JGJ, Bindels RJM, De Baaij 
JHF. (2016) Hypomagnesemia inType 2 Diabetes: A 
Vicious Circle? Diabetes. 65 (1) -13 
 
Guerrero-Romero   F,  Rodríguez-Morán   M.  (2006)  
Hypomagnesemia,   oxidative  stress,inflammation, and 
metabolic syndrome. Diabetes Metab Res Rev. 22: 471-
476. 
 
Guerrero-Romero  F, Rodríguez-Morán  M.  (2013)  
Serum  Mg in the metabolically  obese normal-weight 
and healthy-obese subjects. Eur J Intern Med. 24: 639-
643. 
 
Guerrero-Romero F,  Tamez-Perez   HE,  Gonzalez-
Gonzalez   G,  Salinas-Martinez   AM, 
Montes-Villarreal J,  Trevino-Ortiz  JH,  et  al.(2004) 
OralMagnesium  supplementation improves insulin 
sensitivity in non-diabetic  subjects with insulin 
resistance. Double-blind 
placebo-controlled randomized trial. Diabetes Metab. 
30(3): 253-258 
 
Huerta MG, Roemmich JN, Kington ML, Bobvjerg VE, 
Weltman AL, Holmes VF, et al. 
(2005) Magnesium  Deficiency  Is Associated  With 
Insulin Resistance  in Obese Children. 
Diabetes Care. 28:1175-1181. 
 
Huguette YMF, Boris AKG, Raïssa NF, Laure NJ, Julius 
O. (2010) Prevalence of insulin resistance in obese 
Cameroonian women. Journal of Diabetes and 
Endocrinology. 1(2): 19-26. 
Humphries  S, Kushner  H, Falkner B. (1999) Low 
dietary magnesium  is associated  with insulin 
resistance in a sample of young, non diabetic Black 
Americans. Am J Hypertens. 12:747-756. 
 
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, 
Brancati FL: (1999) Serum and dietary magnesium   
and  the  risk for  type  2  diabetes   mellitus:   the  
Atherosclerosis   Risk  in 
Communities Study. Arch Intern Med. 159(18):2-2159 
 
Larsson SC, Wolk A. (2007) Magnesium intake and risk 
of type 2 diabetes: a meta-analysis.  J Intern Med. 
262(2): 208-214 
Lebovitz HE. (2001) Insulin resistance: definition and 
consequences. Exp Clin Endocrinol Diabetes. 109 (Suppl 
2):S135-S148 
 
Lopez-Ridaura  R, Willett WC, Rimm EB, Liu S, Stampfer 
MJ, Manson JE, et al. (2004) 
Magnesium intake and risk of type 2 diabetes in men 
and women. Diabetes Care.  27: 134- 140. 
 
Nadler  JL,  Buchanan  T,  Natarajan  R,  Antonipillai   I,  
Bergman   R,  Rude  R.  (1993) Magnesium  deficiency  
produces  insulin  resistance  and increased  
thromboxane  synthesis. Hypertension. 21:1024-1029. 
Oli  JM,  Adeyemo  AA,  Okafor  GO,  Ofoegbu  EN,  
Onyenekwe  B,  Chukwuka  CJ,  et al.(2009) Basal insulin  
resistance  and secretion  in Nigerians with type 2 
diabetes mellitus MetabSyndrRelat Disord.7: 595 599 
 
Paolisso G, Sgambato S, Gambardella A, Pizza G, 
Tesauro P, Varricchio M, et al. (1992) 
Daily magnesium  supplement  improves  glucose  
handling  in elderly subjects.  Am J Clin Nutr. 
55(6):1161-1167 
 
Paul SJ. (2009) Metabolic consequences of 
hyperglycemia  and insulin resistance. Insulin. 
4(1): 2-14 
 
Resnick LM, Gupta RK, Gruenspan H, Alderman MH, 
Laragh JH: (1990) Hypertension and 
peripheral insulin resistance: possible mediating role 
of intracellular free magnesium. Am J Hypertens. 3:373-
379. 
 
Rosolova  H,  Mayer  O  Jr,  Reaven  GM: 
 
(2000)  Insulin-mediated   glucose  disposal  is 
decreased  in  normal  subjects  with  relatively  low  
plasma  magnesium   concentrations.Metabolism. 
49:418-420. 
 
Swaminathan R. (2003) Magnesium Metabolism and its 
Disorders. Clin Biochem Rev. 24:47-66 
 
Wallace TM, Levy JC, Mathews DR. (2004) Use and 
abuse of HOMA modelling. Diabetes Care. 27:1487-
1495. 
 
Young  EE,  Okafor  CN,  Iroezindu  MO,  Agbalu  IS.  
(2016)  Insulin  resistance,  metabolic 
syndrome, and lipids in African women. Niger J Clin 
Pract. 19: 793-798.   
 
